首页 | 本学科首页   官方微博 | 高级检索  
     检索      

纤维结合素多肽衍生物的化学合成及对骨髓瘤细胞株K562的体外抑制作用
引用本文:王洪海,陈佩丽,焦顺昌,周严恒.纤维结合素多肽衍生物的化学合成及对骨髓瘤细胞株K562的体外抑制作用[J].复旦学报(自然科学版),1995(4).
作者姓名:王洪海  陈佩丽  焦顺昌  周严恒
作者单位:复旦大学,解放军总医院,复旦大学遗传学研究所
摘    要:应用固相多肽合成技术,人工合成了一种衍生于纤维结合素的六肽GRGDSS。用高效液相层析进行纯度鉴定,并观察六肽对骨髓瘤细胞株K562的体外抑制作用。实验结果表明,六肽在72h内对骨髓瘤细胞的抑制率为31%;多肽的结构对功能有一定的影响。根据竞争抑制原理,设计和合成多功能的多肽可为临床医学治疗肿瘤开辟一个新的途径。

关 键 词:合成多肽  纤维结合素  肿瘤治疗

Chemical synthesis of hexapeptide derived from fibronectin and its inhibition function on myeloma cell K562 in vitro
Wang Honghai,Chen Peili, Jiao Shunchang,Zhou Yanhen.Chemical synthesis of hexapeptide derived from fibronectin and its inhibition function on myeloma cell K562 in vitro[J].Journal of Fudan University(Natural Science),1995(4).
Authors:Wang Honghai  Chen Peili  Jiao Shunchang  Zhou Yanhen
Institution:Wang Honghai;Chen Peili; Jiao Shunchang;Zhou Yanhen (Fudan University) (The General Hospital of PLA)
Abstract:he paper has reported that hexapeptide derived from fibronectin was synthesized in solid-phase peptide synthesis strategy and its inhibition effect on myeloma cell in vitro. The inhibition rate of myeloma cell K562 by synthetic hexapeptide was 30% or so in 72 hours. The design of multifunctional peptides capable of recognizing specific substrates according to competitive inhibition could lead to reagents for the use in medicine.The application of synthetic peptide to treat tumor may put forward a new route to cure the cancers.
Keywords:ynthetic peptide  fibronectin  treatment for cancer
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号